Skip to content
Recall Observatory FDA recall evidence

Drug product

Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608

D-0330-2021

March 19, 2021

Class III

Product summary

Firm
Asclemed USA Inc. dba Enovachem Pharmaceuticals
Event
Event 87548
Status
Ongoing
Classification
Class III
Quantity
N/A
Official record key
drug-enforcement:D-0330-2021

Official wording

Reason: Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Code information: Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022

Distribution pattern: Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.